OUR COMPANY
ABOUT US
LEADERSHIP TEAM
BOARD OF DIRECTORS
ADVISORS
CAREERS
ABOUT BNCT
HISTORY
HOW IT WORKS
BENEFITS OF BNCT
OUR TECHNOLOGIES
ALPHABEAM NEUTRON SYSTEM
TARGETED BORON DRUGS
NEWS
NEWS
EVENTS
CONTACT US
NEW EBOOK
OUR COMPANY
ABOUT US
LEADERSHIP TEAM
BOARD OF DIRECTORS
ADVISORS
CAREERS
ABOUT BNCT
HISTORY
HOW IT WORKS
BENEFITS OF BNCT
OUR TECHNOLOGIES
ALPHABEAM NEUTRON SYSTEM
TARGETED BORON DRUGS
NEWS
NEWS
EVENTS
CONTACT US
NEW EBOOK
logo_businesswire
Home
>
TAE Life Sciences Identifies Proprietary Drug Candidates to Support Boron Neutron Capture Therapy (BNCT)
>
logo_businesswire
February 12, 2022
Previous Story
TAE Life Sciences Identifies Proprietary Drug Candidates to Support Boron Neutron Capture Therapy (BNCT)